"Even in this time of uncertainty, Mayo Clinic is a place for hope and healing — and we're committed to delivering the care you need. With options for face-to-face, virtual visits or phone appointments in adherence with federal and state executive orders and guidance. Mayo Clinic is the best hospital overall according to U.S. News & World Report. Mayo Clinic treats more than 30,000 people with blood diseases and 150,000 people with cancer, providing the best possible blood cancer care. Mayo Clinic hematologists work in collaboration with teams of top experts from virtually every medical and surgical specialty for the care of adults and children with blood diseases, including various cancers of the blood and bone marrow."

During the past decade, Mayo Clinic - Rochester Hematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mayo Clinic - Rochester Hematology" are "Classical Hodgkin's Lymphoma" (1 trials) and "Lymphoma, Mantle- Cell" (1 trials). Many other conditions were trialed in "Mayo Clinic - Rochester Hematology" in a lesser frequency.

Most popular intervention types in "Mayo Clinic - Rochester Hematology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Everolimus" (1 trials) and "Panobinostat" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mayo Clinic - Rochester Hematology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mayo Clinic - Rochester Hematology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mayo Clinic - Rochester Hematology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mayo Clinic - Rochester Hematology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".